Drug Profile
Choriogonadotropin alfa biosimilar - Reliance Life Sciences
Alternative Names: ChorioRel; R-TPR-020; rhCG - Reliance Life SciencesLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Reliance Life Sciences
- Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones; Recombinant proteins
- Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Female infertility
Most Recent Events
- 20 Mar 2014 Data clean: changed NME to non-NME, based on latest advisory from GW
- 26 Oct 2012 Launched for Female infertility in India (SC) before October 2012
- 09 Dec 2009 Phase-III clinical trials in Female infertility in India (SC)